CLINICAL TRIAL
Accepted on 17 Mar 2025
Neuron-specific enolase in patients with acute and chronic schizophrenia, diversity of approaches: marker of neuronal death, neurodegeneration or neurodevelopmental theory in schizophrenia? A single-center case-control study
doi 10.3389/fpsyt.2025.1520192